D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 

Slides:



Advertisements
Similar presentations
Home care assistance and the utilization of peritoneal dialysis
Advertisements

A skeptical view of assisted home peritoneal dialysis
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
F.H. Bender, J. Bernardini, B. Piraino  Kidney International 
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Buffer transport in peritoneal dialysis
Volume 70, Pages S138-S145 (November 2006)
Iron status and iron supplementation in peritoneal dialysis patients
Volume 70, Pages S38-S43 (November 2006)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Impact of new dialysis solutions on peritonitis rates
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 73, Pages S131-S136 (April 2008)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Volume 74, Issue 7, Pages (October 2008)
Glucose sparing in peritoneal dialysis: Implications and metrics
Volume 63, Issue 1, Pages (January 2003)
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
George A. Kaysen, Burl R. Don
French peritoneal dialysis registry (RDPLF): Outline and main results
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
F.H. Bender, J. Bernardini, B. Piraino  Kidney International 
V. La Milia, M. Limardo, G. Virga, M. Crepaldi, F. Locatelli 
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 73, Pages S81-S86 (April 2008)
The need for reliable serum parathyroid hormone measurements
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Benefits of preserving residual renal function in peritoneal dialysis
Volume 73, Issue 5, Pages (March 2008)
Volume 73, Pages S5-S17 (April 2008)
Volume 73, Pages S94-S101 (April 2008)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.
Blood pressure targets in hemodialysis patients
Recent experience with high-dose intravenous iron administration
In vitro biocompatibility performance of Physioneal
Volume 68, Issue 2, Pages (August 2005)
Volume 70, Issue 10, Pages (November 2006)
Dmytro Khadzhynov, MD, Christian Joukhadar, MD, Harm Peters, MD 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 70, Issue 6, Pages (September 2006)
Microbiology and outcomes of peritonitis in North America
Volume 73, Pages S34-S41 (April 2008)
Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function  S.L.S. Fan, T. Pile, S. Punzalan, M.J.
Future of icodextrin as an osmotic agent in peritoneal dialysis
Volume 60, Issue 6, Pages (December 2001)
Volume 73, Pages S72-S75 (April 2008)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 64, Pages S84-S93 (December 2003)
A skeptical view of assisted home peritoneal dialysis
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Sclerosing encapsulating peritonitis in a 47-year-old woman
Volume 63, Issue 1, Pages (January 2003)
Charles A. Herzog  Kidney International 
Quantification of free water transport in peritoneal dialysis
Volume 70, Issue 3, Pages (August 2006)
Volume 70, Issue 5, Pages (September 2006)
Volume 65, Issue 1, Pages (January 2004)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 58, Issue 4, Pages (October 2000)
Volume 57, Issue 4, Pages (April 2000)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Volume 76, Issue 2, Pages (July 2009)
Metabolic and laboratory effects of icodextrin
Presentation transcript:

The leptin/adiponectin ratio: Potential implications for peritoneal dialysis  D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International  Volume 73, Pages S112-S118 (April 2008) DOI: 10.1038/sj.ki.5002611 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Interactions between PD fluids, omental adipocytes and adipokines. Normal visceral peritoneal morphology showing a thin mesothelial cell layer lying on a thick sheet of omental adipose tissue. PD fluids are transferred by diffusion through the mesothelium, and therefore may interact with omental adipocytes, which synthesize adipokines. Picture at × 10 original magnification; courtesy of Dr P Furness, Department of Histopathology, Leicester General Hospital, UK. Kidney International 2008 73, S112-S118DOI: (10.1038/sj.ki.5002611) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Effect of glucose-based and glucose-free PD fluids on leptin secretion. 3T3-L1 adipocytes in six-well plates were incubated for 48 h in PD4 (glucose 1.36%), ICOD and AA-based PD fluids. M199 was used as the control solution (C). Solutions were diluted 50:50 with M199. Results shown are means±s.e.m. of three independent experiments (pool of 15–28 culture wells for each set of conditions). **P<0.001 vs C. Kidney International 2008 73, S112-S118DOI: (10.1038/sj.ki.5002611) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Effect of glucose-based and glucose-free PD fluids on adiponectin secretion. 3T3-L1 adipocytes in six-well plates were incubated for 48 h in PD4 (glucose 1.36%), ICOD, and AA-based PD fluids. M199 was used as the control solution (C). Solutions were diluted 50:50 with M199. Results shown are means±s.e.m. of three independent experiments (pool of 15–28 culture wells for each set of conditions). *P<0.05 vs C. Kidney International 2008 73, S112-S118DOI: (10.1038/sj.ki.5002611) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Effect of glucose concentration in dialysates on leptin secretion. 3T3-L1 adipocytes in six-well plates were incubated in laboratory-manufactured PD fluids at various glucose concentrations. Solutions were diluted 50:50 with M199. The final glucose concentration in the test media was as shown. Results shown are those obtained at 48 h of incubation (means±s.e.m. of three independent experiments; pool of 22–26 culture wells for each set of conditions). **P<0.001 vs 2.75 mM glucose. Kidney International 2008 73, S112-S118DOI: (10.1038/sj.ki.5002611) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 Acute effect of PD4 3.86% on plasma leptin. PD patients (n=5) were subjected to a 6-h dwell with sequentially a high glucose-containing PD fluid (PD4 3.86%), an AA PD fluid, and no PD fluid (C). Patients fasted overnight and during the protocol. Leptin was assayed in plasma after 3 and 6 h (enzyme-linked immunosorbent assay). Mean±s.e.m. % of plasma leptin changes vs initial values are shown. *P<0.05 vs C and AA. Kidney International 2008 73, S112-S118DOI: (10.1038/sj.ki.5002611) Copyright © 2008 International Society of Nephrology Terms and Conditions